| Literature DB >> 33807065 |
Pascal Arné1,2, Veronica Risco-Castillo1,2,3, Grégory Jouvion2,3, Cécile Le Barzic1, Jacques Guillot2,3.
Abstract
The ubiquitous fungi belonging to the genus Aspergillus are able to proliferate in a large number of environments on organic substrates. The spores of these opportunistic pathogens, when inhaled, can cause serious and often fatal infections in a wide variety of captive and free-roaming wild birds. The relative importance of innate immunity and the level of exposure in the development of the disease can vary considerably between avian species and epidemiological situations. Given the low efficacy of therapeutic treatments, it is essential that breeders or avian practitioners know the conditions that favor the emergence of Aspergillosis in order to put adequate preventive measures in place.Entities:
Keywords: Aspergillus; aspergillosis; bird; wildlife
Year: 2021 PMID: 33807065 PMCID: PMC8004873 DOI: 10.3390/jof7030241
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
First descriptions of mycotic diseases in birds (Urbain and Guillot, 1938).
| Year of Notification | Species | Description |
|---|---|---|
| 1813 | Scaup duck | “Mold or blue mucor” within the air sac |
| 1815 | Eurasian Jay | Parasitic thallus in air sacs, bronchi and lungs |
| 1816 | Mute swan | Green mold in the aerial cavities |
| 1826 | Stork | Mold lining the internal face of air sacs and within long bones |
| 1827 | Raven | Mold in the lungs |
| 1833 | Flamingo | Mold in the pulmonary cavities |
| 1841 | Eider | A fungus in air sacs, bronchi, basin and wing bones; later identified as “ |
| 1841 | Parakeet | Mycotic lesions in the lungs |
| 1842 | Falcon/Owl | Mycotic lesions in the bronchi and air sacs |
| 1842 | Goose/Cormorant/Penguin or Razorbill | Mycotic lesions |
| 1842 | Bullfinch | White mold (“ |
| 1848 | Golden plover | Mold in the air sacs later identified as “ |
| 1853 | Gull/Pheasant | “ |
| 1857 | Golden eagle/Ostrich | Mycelium in the airways |
| 1866 | Parrot | Mold in the lungs |
| 1866 | Loon | Mold in the lungs |
| 1871 | Goshawk | Mold in the air sacs |
| 1873 | Duck | Mold in the airways |
| 1875 | Flamingo | “ |
| 1875 | Great bustard | “ |
| 1880 | Cardinal/Finches/Parrots | Aspergillosis |
| 1883 | Parrot | “ |
| 1883 | Flamingos | Aspergillosis |
| 1885 | Ostrich | “ |
| 1887 | Swan | Aspergillosis |
| 1887 | Pheasant | Aspergillosis |
| 1890 | Ducks | Aspergillosis |
| 1891 | Canari | “ |
| 1894 | Swan | Aspergillosis |
Figure 1Quarterly die-off reports attributed to Aspergillosis in North-American avifauna. (USGS 1981–2014). T1: January to March; T2: April to June; T3: July to September; T4: October to December. * To improve the clarity of the diagram, an episode that occurred in 2011 associated with a very high mortality rate (7000 dead) is not represented in full.
Figure 2Risk factors associated with aspergillosis in migratory birds. Under usual climatic conditions, waterfowl exploit wetlands for food. Weather disturbances can force birds to take refuge on cultivated lands and feed on crop residues that are sometimes heavily contaminated by molds. Under such circumstances, exhausted individuals may suffer from airway clearance dysfunction and develop aspergillosis with a fatal outcome.
Prevalence of aspergillosis in mortality surveys of different birds.
| Species | Period | Location | Status a | % of Aspergillosis | Diagnosis b | Reference |
|---|---|---|---|---|---|---|
| Common loon ( | 1970–1975 | USA | F | 18% (34/190) | G/C | [ |
| 1976–1991 | USA | F | 6% (13/222) | G/C/H | [ | |
| 1970–1994 | USA | F | 7% (31/434) | G/C/H | [ | |
| 1992–1995 | Canada | F | 16% (5/31) | G/D/H | [ | |
| 1979–1999 | USA | F | 31% (33/105) | Uns. | [ | |
| 1987–2000 | USA | F | 3% (14/522) | G/H | [ | |
| Mute swan ( | 1996 |
| F | 14% (2/14) | G/H | [ |
| Bewick’s swan ( | 1951–1989 | UK | F | 5% (7/150) | G/H | [ |
| Trumpeter swan ( | 1986–1992 | USA | F | 21% (18/115) | G | [ |
| Trumpeter swan ( | 2000–2002 | USA | F | 17% (62/365) | G/D | [ |
| Seabirds (Guillemot | 1992–1995 | Belgium | F | 2.9% (6/241) | G/H | [ |
| Herring gulls ( | 1981–1982 | USA | F | 31% (50/161) | G/C/H | [ |
| White stork ( | 2007–2008 | Germany | F | 28% (22/101) | G/C/H/S | [ |
| Eurasian cranes ( | 1998–2008 | Germany | F | 4% (7/143) | G/C/H | [ |
| Whooping crane ( | 1982–1995 | USA | C | 7% (7/103) | G/H | [ |
| Bewick’s swan | 1951–1989 | UK | C | 6.6% (adults) | G/H | [ |
| Seaducks (European Eider | 1959–1976 | USA | C | 17% (adults) | Uns. | [ |
| Shelducks ( | 1959–1976 | USA | C | 16% (adults) | Uns. | [ |
| Perching ducks (Wood duck | 1959–1980 | USA | C | 7.5% (adults) | Uns. | [ |
| Stiff-tailed ducks (Ruddy ducks | 1959–1980 | USA | C | 2% (adults) | Uns. | [ |
| Northern geese (Canada geese | 1959–1980 | USA | C | 4% (adults) | Uns. | [ |
| Falcons (saker falcons | 1998–2001 | Saudi Arabia | C | 10% (13/131) | G/C/H | [ |
| Gentoo penguins ( | 1964–1988 | UK | C | 41% (128/314) | Uns. | [ |
| Magellanic penguins ( | 1986 | USA | C | 61% (23/38) | G/H | [ |
| Magellanic penguins ( | 2008–2018 | USA | C | 27% (23/85) | G/H | [ |
| Psittacine birds (parrots, macaws, cockatoos) | 1998–2017 | Canada | C | 1.7% (32/1850) | H/Uns. | [ |
| Magellanic penguins ( | 2004–2005 | Brazil | R | 42% (5/12) | G/D/C/H | [ |
| Magellanic penguins ( | 2004–2009 | Brazil | R | 20% (66/327) | G/C/H | [ |
| Bald eagle ( | 1975–2013 | USA | R | 1% (35/2980) | Uns. | [ |
| Black-browed Albatross | 2015–2017 | Brazil | R | 14% (3/14) | G/C/H/S ( | [ |
a F = free-ranging birds; C: permanent captivity; R: transitory captivity or rehabilitation; b based on gross lesions (G); direct fungal examination (D); fungal culture (C); histopathology (H); gene(s) sequencing (S); unspecified (Uns.).
Figure 3Lung histopathological lesions compatible with aspergillosis. (A–E) Lung of a knob-billed duck (Sarkidiornis melanotos). (A) Multifocal to coalescing heterophilic granulomas (black arrowheads), (B) displaying necrosis of heterophils and macrophages in their center (*) and (C) a peripheral rim of giant multinucleated cells (black arrowheads). In the granulomas (D) and the lung surface (E), the presence of invading thin (3- to 12 µm), non-pigmented (hyaline), septated hyphae with homogenous acute angle branching consistent with Aspergillus spp. (F) Lung of a red-crested pochard (Netta rufina) with numerous Aspergillus spp. conidial heads. (A–C): HES staining; (D–F): Gomori Grocott staining.
Bioavailability and efficacy of different antifungal agents tested experimentally in several avian species.
| Antifungal Agent | Status/Species | Administration Route | Dose | Aim | Main Conclusions | References |
|---|---|---|---|---|---|---|
| Amphotericin B | Mallard ducks | Intratracheal nebulization | 3 mg/kg (single) | PK | Target dose of 1 µg/g of lungs reached (up to 9 days) | [ |
| Terbinafine | Shelduck | Oral | 60 mg/kg (single dose) | PK | No adverse effects | [ |
| Terbinafine | African penguins | Oral | 3/7/15 mg/kg (single dose) | PK | 15 mg/kg per day oral dose = putative treatment | [ |
| Terbinafine | Red-tailed hawks | Oral | 15/30/60 mg/kg | PK | A dose of 22 mg/kg SID may be a potential treatment option to treat aspergillosis in raptors | [ |
| Terbinafine | Hispanolian amazons | Oral | 60 mg/kg (single) | PK | No adverse effect | [ |
| Terbinafine | Hispanolian amazons | Nebulization (15 min) | 1 mg/mL solution | PK | Plasma concentration above the target dose up to 4 hr | [ |
| Itraconazole | African penguins | Oral | 20 mg/kg (single dose) | PK | Putative cost effective treatment | [ |
| Itraconazole | Lesser flamingos | Oral | 10 mg/kg (single dose) | PK | Plasma drug concentration > 0.5 µg/mL maintained for at least 24 h after a single dose | [ |
| Itraconazole | Humboldt penguins | Oral (in a fish) | 6/12 mg/kg SID/BID | PK | 8.5 mg/kg BID or 20 mg/kg SID of commercial capsule may provide adequate steady-state therapeutic blood levels | [ |
| Itraconazole | Japanese quail | Nebulization (30 min) | 4%/10% suspension | EAA | 10% nanosuspension is well tolerated and alleviates acute aspergillosis | [ |
| Itraconazole | Falcon ( | Nebulization (15 min) | NS | - | No toxic effects on A594 cells | [ |
| Voriconazole | Falcons ( | Oral (crop gavage or incorporated into meat) | 12.5 mg/kg BID 7/14 days | PK/ET | High interindividuality of voriconazole/no adverse effects | [ |
| Voriconazole | African penguins | Oral | 5 mg/kg (single dose) | PK | Effective for the treatment of aspergillosis | [ |
| Voriconazole | Magellanic penguins | Oral (in a herring) | 2.5/5 mg/kg (single dose) | PK | Above the target dose for least 24 h following the highest dose | [ |
| Voriconazole | Hispanolian amazons | Oral | 12/24 mg/kg (single dose) | PK | Decrease in plasma concentration following administration of multiple doses requiring adjustment | [ |
| Voriconazole | Red-tailed hawks | Oral (gavage) | 10 mg/kg (single dose) | PK | More frequent dosing (up to QID) may be necessary to maintain target concentration during prolonged therapy | [ |
| Voriconazole | Falcons ( | Intramuscular injection | 12.5 mg/kg (single dose) | PK | Target plasma concentration (> 1 µg/ml) maintained 16 to 20 h without clinical side effects | [ |
| Voriconazole | Mallard ducks | Intravenous injection | 10 mg/kg (single dose) | PK | No overt/histological signs of toxicity | [ |
| Voriconazole | Japanese quail | Oral | 20/40 mg/kg SID | PK/EAA | Prolonged survival and less fungal burden in the lungs with the highest dose. No necrotic lesions (histopathology | [ |
| Voriconazole | Rock pigeon | Oral | 10 mg/kg BID | EAA | Reduction of clinical signs and | [ |
BID: twice a day; EAA: experimental acute aspergillosis; ET: empirical treatment on birds with spontaneous aspergillosis; NS: not specified; PK: pharmacokinetic studies; QID: four times per day; SC: subcutaneous; SID: once per day.
Antifungal treatments recommended for avian aspergillosis [4,99,241].
| Avian Taxon | Antifungal Agent | Dose and Administration Route |
|---|---|---|
| Gamebirds | Itraconazole | 10 mg/kg orally SID or BID |
| Terbinafine | 15 mg/kg orally BID | |
| Parrots | Amphotericin B | Nebulization 1 mg/kg diluted to 1 mL with sterile water BID or TID |
| Itraconazole | 5–10 mg/kg orally SID or BID | |
| 2.5–5 mg/kg orally SID in Grey parrot | ||
| Voriconazole | 12–18 mg/kg orally BID | |
| Raptors | Itraconazole | 10 mg/kg orally BID for 60 days |
| 5–10 mg/kg orally BID for 5 days then SID for 60-90 days | ||
| Terbinafine | 10–15 mg/kg orally BID for 6-8 weeks | |
| Voriconazole | 10–18 mg/kg orally BID for 60 days | |
| 12.5 mg/kg orally BID in falcons | ||
| Seabirds | Itraconazole | 10–20 mg/kg orally SID |
| Waterfowl | Amphotericin B | Nebulization 12.5 mg diluted with 2.5 mL sterile water SID for 7 days |
| 7.5 mg/kg intratracheally TID | ||
| 3.25 mg/kg intravenously (in fluids) over 24 h | ||
| Itraconazole | 5–10 mg/kg orally SID for 4-8 weeks |
BID: twice per day; TID: three times per day; SID: once per day.